About
Moon by Diploid is an advanced artificial intelligence platform built specifically for rare disease diagnostics. It combines natural language processing of clinical phenotypes with deep analysis of genomic variants to surface the most likely diagnoses for complex, undiagnosed patients. Clinicians input patient symptoms using Human Phenotype Ontology (HPO) terms, and Moon cross-references thousands of known genetic disorders against sequencing results to rank candidate diagnoses with supporting evidence. The platform integrates seamlessly into clinical laboratory workflows, supporting variant interpretation pipelines for whole-exome sequencing (WES) and whole-genome sequencing (WGS). Moon dramatically reduces the time-to-diagnosis for rare disease patients — a process that historically takes years — by automating the most labor-intensive steps of variant prioritization and literature matching. Diploid, the company behind Moon, was acquired by Invitae, which is now part of Labcorp, bringing Moon's AI capabilities into one of the largest genetic testing networks globally. Moon is trusted by leading academic medical centers, pediatric hospitals, and genetic testing laboratories to improve diagnostic yields and deliver more actionable insights to patients and their families. It is particularly well-suited for pediatric rare diseases, neurological conditions, and cases involving large gene panels.
Key Features
- AI-Driven Variant Prioritization: Automatically ranks genetic variants from WES/WGS data by likelihood of pathogenicity, drastically reducing manual review time.
- HPO-Based Phenotype Matching: Accepts standardized Human Phenotype Ontology (HPO) terms to match patient symptoms against thousands of known rare genetic disorders.
- Integrated Clinical Decision Support: Fits directly into laboratory and hospital workflows, providing ranked differential diagnoses with supporting evidence for each candidate.
- Broad Disease Coverage: Covers a wide spectrum of rare diseases including pediatric, neurological, cardiological, and metabolic conditions.
- Collaborative Genetic Counseling Support: Facilitates communication between geneticists, clinicians, and genetic counselors by providing structured, evidence-backed diagnostic reports.
Use Cases
- Clinical geneticists diagnosing pediatric patients with suspected rare genetic disorders using whole-exome sequencing data.
- Diagnostic laboratories integrating AI variant prioritization into their WGS/WES reporting pipelines to improve throughput and diagnostic yield.
- Academic medical centers running rare disease programs where rapid and accurate genetic diagnosis is critical for treatment decisions.
- Genetic counselors reviewing AI-ranked differential diagnoses to better communicate findings and next steps to patients and families.
- Hospital genetics departments reducing the diagnostic odyssey for undiagnosed patients by leveraging AI-assisted phenotype-genotype matching.
Pros
- Dramatically Reduces Time-to-Diagnosis: Automates the most time-consuming parts of rare disease workup, compressing a process that often takes years into days or hours.
- High Diagnostic Yield: AI-powered prioritization improves the rate of successful diagnoses compared to manual variant interpretation alone.
- Seamless Lab Integration: Designed to plug into existing clinical sequencing pipelines with minimal disruption to established workflows.
- Backed by Large-Scale Genetic Network: Integration with Invitae/Labcorp's extensive testing infrastructure ensures broad access and continuous improvement of the AI models.
Cons
- Enterprise/Clinical Pricing: Moon is a professional clinical tool with pricing tailored to labs and hospitals, making it inaccessible for individual researchers or small practices on limited budgets.
- Requires Quality Genomic Input: Diagnostic accuracy is dependent on the quality of sequencing data and the completeness of phenotype information provided by the clinician.
- Limited Public Documentation: As an enterprise clinical solution, detailed technical documentation and pricing are not publicly available, requiring direct contact for evaluation.
Frequently Asked Questions
What is Moon by Diploid?
Moon is an AI-powered rare disease diagnosis platform that analyzes patient clinical features (symptoms) and genomic sequencing data to rank the most likely genetic diagnoses and pathogenic variants.
What types of sequencing data does Moon support?
Moon supports whole-exome sequencing (WES) and whole-genome sequencing (WGS) data, allowing comprehensive variant analysis across a patient's genome.
How does Moon use patient symptoms?
Clinicians enter patient phenotypes using Human Phenotype Ontology (HPO) terms, which Moon uses to match against known rare disease profiles and prioritize the most relevant genetic variants.
Who acquired Diploid, the maker of Moon?
Diploid was acquired by Invitae, a leading genetic testing company that has since become part of Labcorp, integrating Moon's AI capabilities into one of the world's largest genetic testing networks.
Is Moon suitable for clinical laboratory use?
Yes, Moon is specifically designed for clinical and diagnostic laboratory environments, integrating into existing sequencing workflows to assist geneticists and clinicians with rare disease case interpretation.
